AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. QNTM
  4. [SCHEDULE 13G/A] Quantum Biopharma Ltd. Class B Subordinate Voting Shares SEC Filing

[SCHEDULE 13G/A] Quantum Biopharma Ltd. Class B Subordinate Voting Shares SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock QNTM logo
Quantum BioPharma Ltd

NASDAQ:QNTM

QNTM Rankings

#7145 Ranked by Market Cap
N/A Ranked by Dividends

QNTM Latest News

Aug 5, 2025
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
Aug 4, 2025
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
Jul 31, 2025
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
Jul 22, 2025
Quantum BioPharma Makes Strategic Investment in GameStop Corp.
Jul 8, 2025
Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

QNTM Latest SEC Filings

Aug 5, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Jul 22, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Jul 10, 2025
[SCHEDULE 13G/A] Quantum Biopharma Ltd. Class B Subordinate Voting Shares SEC Filing

QNTM Stock Data

81.14M
2.54M
8.79%
23.8%
3.99%
Biotechnology
Healthcare
Canada
Toronto